These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16543200)

  • 21. [New strategies in the management of retinoblastoma].
    Balmer A; Munier F; Zografos L
    J Fr Ophtalmol; 2002 Feb; 25(2):187-93. PubMed ID: 11941242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Available approaches to retinoblastoma therapy--literature review].
    Morawski K; Kulig-Stochmal A; Drychowska-Jęmhorska JJ; Kuhicka-Trząska A; Romanowska-Dixon B
    Klin Oczna; 2015; 117(1):45-9. PubMed ID: 26349159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pupillary distortion and staphyloma following trans-scleral contact diode laser cyclophotocoagulation: a clinicopathological study of three patients.
    Bhola RM; Prasad S; McCormick AG; Rennie IG; Talbot JF; Parsons MA
    Eye (Lond); 2001 Aug; 15(Pt 4):453-7. PubMed ID: 11767018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitreoretinal complications of retinoblastoma treatment.
    Tawansy KA; Samuel MA; Shammas M; Murphree AL
    Retina; 2006 Sep; 26(7 Suppl):S47-52. PubMed ID: 16946679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?
    Gombos DS; Cauchi PA; Hungerford JL; Addison P; Coen PG; Kingston JE
    Br J Ophthalmol; 2006 Sep; 90(9):1168-72. PubMed ID: 16707528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
    Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frontiers in the management of retinoblastoma.
    Lin P; O'Brien JM
    Am J Ophthalmol; 2009 Aug; 148(2):192-8. PubMed ID: 19477707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Retinoblastoma in 2015: Agreement and Disagreement.
    Abramson DH; Shields CL; Munier FL; Chantada GL
    JAMA Ophthalmol; 2015 Nov; 133(11):1341-7. PubMed ID: 26378747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma.
    Schmack I; Hubbard GB; Kang SJ; Aaberg TM; Grossniklaus HE
    Am J Ophthalmol; 2006 Aug; 142(2):310-5. PubMed ID: 16876514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma.
    Abramson DH; Frank CM; Dunkel IJ
    Ophthalmology; 1999 Oct; 106(10):1947-50. PubMed ID: 10519590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cavitary retinoblastoma: ultrasonographic and fluorescein angiographic findings in 3 cases.
    Palamar M; Pirondini C; Shields CL; Shields JA
    Arch Ophthalmol; 2008 Nov; 126(11):1598-600. PubMed ID: 19001231
    [No Abstract]   [Full Text] [Related]  

  • 32. The treatment of retinoblastoma: a case study.
    Tomlinson D
    J Pediatr Oncol Nurs; 2001; 18(2):50-4. PubMed ID: 11279590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management and outcome of unilateral retinoblastoma.
    Mallipatna AC; Sutherland JE; Gallie BL; Chan H; Héon E
    J AAPOS; 2009 Dec; 13(6):546-50. PubMed ID: 20006813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model.
    Jockovich ME; Suarez F; Alegret A; Piña Y; Hayden B; Cebulla C; Feuer W; Murray TG
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5371-6. PubMed ID: 18055783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoreduction for intraocular retinoblastoma in Malaysia.
    Menon BS; Juraida E; Alagaratnam J; Mohammad M; Ibrahim H; George TM; Ariffin H; Ho C; Khuzaiah R; Peng LH
    J Pediatr Hematol Oncol; 2007 Jan; 29(1):2-4. PubMed ID: 17230058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic carboplatin for retinoblastoma: change in tumour size over time.
    Abramson DH; Lawrence SD; Beaverson KL; Lee TC; Rollins IS; Dunkel IJ
    Br J Ophthalmol; 2005 Dec; 89(12):1616-9. PubMed ID: 16299142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma].
    Balwierz W; Kobylarz J; Starzycka M; Dluzniewska A
    Med Wieku Rozwoj; 2001; 5(3 Suppl 1):15-23. PubMed ID: 12004148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
    Greenwald MJ; Goldman S; Strauss LC
    Ophthalmology; 1998 Sep; 105(9):1579-81. PubMed ID: 9776658
    [No Abstract]   [Full Text] [Related]  

  • 39. Psychosocial determinants for treatment decisions in familial retinoblastoma.
    Soliman SE; Ulster A; MacDonald H; VandenHoven C; Toi A; Hèon E; Gallie B
    Ophthalmic Genet; 2017; 38(4):392-394. PubMed ID: 28085520
    [No Abstract]   [Full Text] [Related]  

  • 40. [Retinoblastoma: preliminary results of national treatment protocol at Casablanca university medical center].
    El Kettani A; Aderdour S; Daghouj G; Knari S; Zaghloul K; Zafad S; Harif M; Benchekroun S
    J Fr Ophtalmol; 2014 Feb; 37(2):115-24. PubMed ID: 24507074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.